- Home
- WATT vs ATHA Comparison
WATT vs ATHA Comparison
Compare WATT & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- ATHA
- Stock Information
- Founded
- WATT 2012
- ATHA 2011
- Country
- WATT United States
- ATHA United States
- Employees
- WATT N/A
- ATHA N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- WATT Technology
- ATHA Health Care
- Exchange
- WATT Nasdaq
- ATHA Nasdaq
- Market Cap
- WATT 9.9M
- ATHA 10.6M
- IPO Year
- WATT 2014
- ATHA 2020
- Fundamental
- Price
- WATT $0.28
- ATHA $0.31
- Analyst Decision
- WATT
- ATHA Buy
- Analyst Count
- WATT 0
- ATHA 4
- Target Price
- WATT N/A
- ATHA $11.25
- AVG Volume (30 Days)
- WATT 569.9K
- ATHA 1.3M
- Earning Date
- WATT 08-07-2025
- ATHA 07-31-2025
- Dividend Yield
- WATT N/A
- ATHA N/A
- EPS Growth
- WATT N/A
- ATHA N/A
- EPS
- WATT N/A
- ATHA N/A
- Revenue
- WATT $1,047,000.00
- ATHA N/A
- Revenue This Year
- WATT $1,028.91
- ATHA N/A
- Revenue Next Year
- WATT N/A
- ATHA N/A
- P/E Ratio
- WATT N/A
- ATHA N/A
- Revenue Growth
- WATT 137.41
- ATHA N/A
- 52 Week Low
- WATT $0.12
- ATHA $0.22
- 52 Week High
- WATT $2.70
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- WATT 52.37
- ATHA 49.52
- Support Level
- WATT $0.25
- ATHA $0.29
- Resistance Level
- WATT $0.29
- ATHA $0.35
- Average True Range (ATR)
- WATT 0.02
- ATHA 0.03
- MACD
- WATT 0.00
- ATHA -0.00
- Stochastic Oscillator
- WATT 60.00
- ATHA 14.10
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.